Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-03-05 @ 3:42 PM
Study NCT ID:
NCT03829033
Status:
RECRUITING
Last Update Posted:
2021-09-01
First Post:
2019-02-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.
Sponsor:
Lund University Hospital
Organization:
Study Overview
Official Title:
Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.
Status:
RECRUITING
Status Verified Date:
2021-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARTSCAN V
Brief Summary:
In this trial, patients with early squamous cell carcinoma of the tonsil with clinical stage T1-2 (p16-positive or p16-negative) N0-1 (p16-positive)/N0-N2b (p16-negative) according to American Joint Committee on Cancer (AJCC) 8th edition, aimed for unimodal and ipsilateral treatment with radiotherapy with curative intent will be included. The patients will be randomized to in a 1:1 ratio to receive radiotherapy with either photons (conventional radiotherapy) versus radiotherapy with protons.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: